Javelin Oncology, Inc.
Biotechnology company · Lebanon, New Hampshire, United States
Javelin Oncology, Inc. is a biotechnology company headquartered in Lebanon, New Hampshire, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $622,843 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2019.
Javelin Oncology at a glance
What does Javelin Oncology do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $622,843 in total (2019 to 2022). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1.5 million sold (2019).
Frequently asked questions about Javelin Oncology
Where is Javelin Oncology headquartered?
Javelin Oncology, Inc. is headquartered in Lebanon, New Hampshire, United States.
What does Javelin Oncology do?
Javelin Oncology, Inc. is a biotechnology company.
When was Javelin Oncology founded?
The earliest incorporation on record for Javelin Oncology, Inc. is in 2017, according to public company registers.
Similar companies
- Celdara Medical, LLCLebanon, New Hampshire, United States
- Lodestone Biomedical, Inc.Lebanon, New Hampshire, United States
- Immunext PharmaceuticalsLebanon, New Hampshire, United States
- Stealth Biologics LLCLebanon, New Hampshire, United States
- Lyticon LLCLebanon, New Hampshire, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences